GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (LSE:AGL) » Definitions » Net Change in Cash

ANGLE (LSE:AGL) Net Change in Cash : £-4.28 Mil (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is ANGLE Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ANGLE's Net Change in Cash for the six months ended in Jun. 2024 was £1.66 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was £-4.28 Mil.

ANGLE Net Change in Cash Historical Data

The historical data trend for ANGLE's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Net Change in Cash Chart

ANGLE Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.37 8.32 19.76 0.06 -15.68

ANGLE Semi-Annual Data
Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.34 11.40 -9.73 -5.94 1.66

ANGLE Net Change in Cash Calculation

ANGLE's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-14.458+-0.203+-1.125+0.108
=-15.68

ANGLE's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-6.795+0.058+8.372+0.029
=1.66

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-4.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANGLE Net Change in Cash Related Terms

Thank you for viewing the detailed overview of ANGLE's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ANGLE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (LSE:AGL) » Definitions » Net Change in Cash
Comparable Companies
LSE:ABDX LSE:GDR LSE:VRCI LSE:PRM LSE:GENI LSE:LLAI TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA LH SHSE:603259 DGX ICLR
Traded in Other Exchanges
ANPCY:USA DWV:Germany
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
Website
https://www.angleplc.com
ANGLE PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.